Vlassopoulos D, Deray G, Carayon A, Maistre G, Jacobs C
Department of Nephrology, Hôpital Pitié-Salpêtrière, Paris, France.
Nephron. 1995;69(3):273-6. doi: 10.1159/000188469.
We have determined the plasma levels of endothelin-1 (ET-1) in patients with end-stage renal disease treated with continuous ambulatory peritoneal dialysis (CAPD). In 10 CAPD patients mean plasma ET levels (7.01 +/- 0.5 pg/ml) were found higher than in normal subjects (3.6 +/- 0.6 pg/ml). Peritoneal clearance of ET-1 was 1.58 +/- 0.12 ml/min and 2.3 +/- 0.2 ml/min during an isotonic peritoneal exchange and a hypertonic exchange, respectively. Plasma ET-1 levels decreased slightly but significantly during a hypertonic 4-hour exchange (from 7.01 +/- 0.5 to 6.14 +/- 0.4 pg/ml) (p < 0.05) and were not modified by an isotonic 4-hour exchange (from 5.7 +/- 0.5 to 6.4 +/- 0.4 pg/ml). ET-1 is known to be an important vascular stimulant and thus elevated ET-1 levels may play a role in the genesis of cardiovascular complications which are the leading cause of mortality in these patients.
我们测定了接受持续性非卧床腹膜透析(CAPD)治疗的终末期肾病患者血浆内皮素-1(ET-1)水平。10例CAPD患者的血浆ET平均水平(7.01±0.5 pg/ml)高于正常受试者(3.6±0.6 pg/ml)。在等渗腹膜交换和高渗交换过程中,ET-1的腹膜清除率分别为1.58±0.12 ml/min和2.3±0.2 ml/min。在4小时的高渗交换过程中,血浆ET-1水平略有下降但具有显著性差异(从7.01±0.5降至6.14±0.4 pg/ml)(p<0.05),而在4小时的等渗交换过程中血浆ET-1水平未发生改变(从5.7±0.5至6.4±0.4 pg/ml)。已知ET-1是一种重要的血管刺激物,因此ET-1水平升高可能在心血管并发症的发生中起作用,而心血管并发症是这些患者死亡的主要原因。